Biomarkers play an essential role in cancer research, where they are often detected by IHC. Because IHC provides visual context to a tumor and the surrounding tumor microenvironment, it can reveal unique insights into cancer development and progression.
Detecting biomarkers by IHC requires highly specific, rigorously validated antibody reagents. You can find these in the new CST guide, which contains a comprehensive list of some of the most critical biomarkers for cancer research.
For Research Use Only. Not for Use in Diagnostic Procedures.© 2023 Cell Signaling Technology, Inc. All Rights Reserved.